Etodolac and Post-bleaching Sensitivity

Clinical trial NCT02881619 · COMPLETED

Trial details

NCT number: NCT02881619
Sponsor: Flavia Pardo Salata Nahsan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Medicaments Substances in Therapeutic Use

Start date: 2014-11-01
Primary completion: 2015-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.